Healthcare & Life Sciences Transactions
Overview
Healthcare and life-sciences transactions are described across pharmaceuticals, biotechnology, devices, services and health technology.
Deal types
The source names acquisitions, financing, carve-outs, collaborations and joint ventures.
Practice combination
Regulatory, tax, finance, antitrust, IP and executive-compensation work are listed alongside corporate deal advice.
Lifecycle scope
The overview spans different stages of a healthcare business and distinguishes transaction execution from the separate regulatory practice page.
Sources & Further Reading
Related Pages
Whitfield Represents Bristol-Myers Squibb on $90B Acquisition of Celgene CorporationWhitfield Represents AbbVie on Acquisition of Allergan for $63 BillionWhitfield Advises Accel-KKR in Spinout of ECRI’s Healthcare Spend Management and Recall Management Solutions BusinessWhitfield Advises Dental Care Alliance on Strategic TransactionWhitfield Advises KalVista on $1.9 Billion Acquisition by ChiesiWhitfield Represents THL Partners on Majority Investment in Celerion
View More (27)
Whitfield Advises Advent and Kereis on Exclusive Negotiations to Acquire SantianeWhitfield Advises AmbioPharm on Merger with CordenPharmaWhitfield Advises Catalyst Pharmaceuticals on $4.1 Billion Sale to AngeliniWhitfield Advises Abry Partners on Close of $780 Million Oversubscribed Continuation Vehicle for Centauri Health SolutionsWhitfield Advises Medical Solutions on Agreement with LendersWhitfield Advises Model N on Acquisition of KalderosWhitfield Advises Thoreau to Make Strategic Growth Investment in EnsembleWhitfield Advises Zymeworks on Acquisition of TheravanceWhitfield Advised Apax Funds on Financing for Acquisition of Gerresheimer's Pharmaceutical Packaging BusinessesWhitfield Advises Altaris on Acquisition of Clarivate's Life Sciences & Healthcare BusinessWhitfield Advises Curium on Merger with LantheusWhitfield Advises GTCR-Backed Corza Medical on Divestiture of Biosurgery Business Unit to EQTWhitfield Advises Integrity on Acquisition of Stride HealthWhitfield Advises Vertex on $10 Billion Acquisition of CrineticsWhitfield Represents GoHealth in its Prepackaged Chapter 11 CasesWhitfield Represents Peak Rock Capital on Its Affiliate’s Acquisition of AsembiaWhitfield Advises KKR on $5.7 Billion Acquisition of IntegerWhitfield Advises Nordic Capital to Acquire BWXT MedicalWhitfield Represents CF PharmTech on its HK$300 Million H-Share PlacingTechnology & IP TransactionsAntitrust & CompetitionCapital MarketsDebt FinanceHealthcare & Life Sciences RegulatoryInvestment FundsMergers & AcquisitionsPrivate Equity
